Wednesday, September 17, 2025
HomeFinTechBioGenCell: Completes $16M in Seed Funding

BioGenCell: Completes $16M in Seed Funding

BioGenCell Completes $16M in Seed Funding

  • BioGenCell, a Netanya, Israel-based biotechnology company, raised $16M in Seed funding
  • The round was led by Marius Nacht
  • The company intends to use the funds to accelerate its development efforts
  • The company  is a biotechnology company that develops technology for using stem cells from the patient’s own blood to treat microvascular diseases
  • Bio GenCell’s medical platform focuses on the needs of patients and physicians
  • The current product treats severe limb-threatening ischemia (CLI) typically found in patients with diabetes and heavy smokers
RELATED ARTICLES
- Advertisment -

Most Popular

Recent Comments